Arsenic Trioxide Induces Differentiation of CD133 + Hepatocellular Carcinoma Cells and Prolongs Posthepatectomy Survival by Targeting GLI1 Expression in a Mouse Model
Ke-Zhi Zhang,Qiang-Bo Zhang,Quan-Bao Zhang,Hui-Chuan Sun,Jian-Yang Ao,Zong-Tao Chai,Xiao-Dong Zhu,Lu,Yuan-Yuan Zhang,Yang Bu,Ling-Qun Kong,Zhao-You Tang
DOI: https://doi.org/10.1186/1756-8722-7-28
IF: 28.5
2014-01-01
Journal of Hematology & Oncology
Abstract:Background Cancer stem cells (CSCs) play a key role in the posthepatectomy recurrence of hepatocellular carcinoma (HCC). CD133 + HCC cells exhibit liver CSC–like properties, and CSC differentiation–inducing therapy may lead these cells to lose their self-renewal ability and may induce terminal differentiation, which may in turn allow their malignant potential to be controlled. Because arsenic trioxide (As 2 O 3 ) increases remission rates and prolongs survival among patients with acute promyelocytic leukemia by inducing differentiation and apoptosis of leukemic cells, we hypothesized that As 2 O 3 might also inhibit HCC recurrence and prolong survival time after hepatectomy by inducing differentiation of HCC CSCs. Methods We evaluated the As 2 O 3 induced differentiation of human HCC CSCs and its mechanism in vitro , and we investigated the effects of treatment with As 2 O 3 on recurrence rates and median survival in a mouse xenograft model. Results We found that As 2 O 3 induced HCC CSC differentiation by down-regulating the expression of CD133 and some stemness genes, thus inhibiting the cells’ self-renewal ability and tumorigenic capacity without inhibiting their proliferation in vitro. In vivo experiments indicated that As 2 O 3 decreased recurrence rates after radical resection and prolonged survival in a mouse model. As 2 O 3 , which shows no apparent toxicity, may induce HCC CSC differentiation by down-regulating the expression of GLI1 . Conclusions We found that As 2 O 3 induced HCC CSC differentiation, inhibited recurrence, and prolonged survival after hepatectomy by targeting GLI1 expression. Our results suggest that the clinical safety and utility of As 2 O 3 should be further evaluated.